These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 31953039)
1. miR-431 Promotes Metastasis of Pancreatic Neuroendocrine Tumors by Targeting DAB2 Interacting Protein, a Ras GTPase Activating Protein Tumor Suppressor. Zhang T; Choi S; Zhang T; Chen Z; Chi Y; Huang S; Xiang JZ; Du YN Am J Pathol; 2020 Mar; 190(3):689-701. PubMed ID: 31953039 [TBL] [Abstract][Full Text] [Related]
2. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells. Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215 [TBL] [Abstract][Full Text] [Related]
4. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression. Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444 [TBL] [Abstract][Full Text] [Related]
5. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression. Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121 [TBL] [Abstract][Full Text] [Related]
6. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1252-5p, regulated by Myb, inhibits invasion and epithelial-mesenchymal transition of pancreatic cancer cells by targeting NEDD9. Xue Y; Wu T; Sheng Y; Zhong Y; Hu B; Bao C Aging (Albany NY); 2021 Jul; 13(14):18924-18945. PubMed ID: 34314382 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus miR-BART1-3p suppresses apoptosis and promotes migration of gastric carcinoma cells by targeting DAB2. Min K; Kim JY; Lee SK Int J Biol Sci; 2020; 16(4):694-707. PubMed ID: 32025216 [TBL] [Abstract][Full Text] [Related]
9. Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer. Liu M; Zhang Y; Yang J; Zhan H; Zhou Z; Jiang Y; Shi X; Fan X; Zhang J; Luo W; Fung KA; Xu C; Bronze MS; Houchen CW; Li M Gastroenterology; 2021 Apr; 160(5):1771-1783.e1. PubMed ID: 33421513 [TBL] [Abstract][Full Text] [Related]
10. A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis. Michael IP; Saghafinia S; Hanahan D Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24184-24195. PubMed ID: 31704767 [TBL] [Abstract][Full Text] [Related]
11. MEG3 Suppresses Human Pancreatic Neuroendocrine Tumor Cells Growth and Metastasis by Down-Regulation of Mir-183. Zhang YY; Feng HM Cell Physiol Biochem; 2017; 44(1):345-356. PubMed ID: 29132136 [TBL] [Abstract][Full Text] [Related]
12. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618 [TBL] [Abstract][Full Text] [Related]
13. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition. Wang C; Yin W; Liu H J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845 [TBL] [Abstract][Full Text] [Related]
15. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors. Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells. Dang X; Ma A; Yang L; Hu H; Zhu B; Shang D; Chen T; Luo Y Cancer Genet; 2012 Mar; 205(3):113-23. PubMed ID: 22469510 [TBL] [Abstract][Full Text] [Related]
17. miR-506 regulates breast cancer cell metastasis by targeting IQGAP1. Sun G; Liu Y; Wang K; Xu Z Int J Oncol; 2015 Nov; 47(5):1963-70. PubMed ID: 26398880 [TBL] [Abstract][Full Text] [Related]
18. MiR-93 functions as a tumor promoter in prostate cancer by targeting disabled homolog 2 (DAB2) and an antitumor polysaccharide from green tea (Camellia sinensis) on their expression. Yang K; Li YW; Gao ZY; Xiao W; Li TQ; Song W; Zheng J; Chen H; Chen GH; Zou HY Int J Biol Macromol; 2019 Mar; 125():557-565. PubMed ID: 30543885 [TBL] [Abstract][Full Text] [Related]
19. miR-363 acts as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2. He F; Fang L; Yin Q Oncol Rep; 2019 May; 41(5):2729-2738. PubMed ID: 30896877 [TBL] [Abstract][Full Text] [Related]
20. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression. Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]